DURHAM, NC, Jan. 17, 2025 (GLOBE NEWSWIRE) — Shares of Scorpius Holdings, Inc (NYSE American: SCPX) (Scorpius or the Company), an integrated contract development and manufacturing organization (CDMO), today announced that the Company is planning a 1 to 20 stock split (Reverse Stock Split) of stock of its common (Common Stock) announced yesterday, will not work.
Shares of Scorpius Holdings, Inc.
Scorpius Holdings, Inc. is an integrated contract development and manufacturing organization (CDMO) focused on the rapid development of biologic systems in the clinic and beyond. Scorpius provides a comprehensive range of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities in San Antonio, TX. With an experienced team and new, purpose-built US facilities, Scorpius is committed to transparent and flexible, high-quality biologics biomanufacturing. For more information, please visit www.scorpiusbiologics.com.
Media liaison and investor relations
David Waldman
+1 919 289 4017
ir@scorpiusbiologics.com
Source: Scorpius Holdings, Inc.
